Patent directory · USPTO A61K / A61P
Patents matching “REGENERON PHARMACEUTICALS, INC.”
837 pharma patents match "REGENERON PHARMACEUTICALS, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 837 pharmaceutical patents matching "REGENERON PHARMACEUTICALS, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11825819
Crnn loss of function rodent model
granted -
US 11820826
Anti-NPR1 antibodies and uses thereof
granted -
US 11820815
Human antibodies to human delta like ligand 4
granted -
US 11820982
Treatment of ophthalmic conditions with son of Sevenless 2 (SOS2) inhibitors
granted -
US 11814428
Anti-PTCRA antibody-drug conjugates and uses thereof
granted -
US 11806398
Citrate buffered VEGF antagonist formulations
granted -
US 11787867
Anti-GITR antibodies and uses thereof
granted -
US 11786606
Site-specific quantitation of drug conjugations
granted -
US 11786603
Optimized transglutaminase site-specific antibody conjugation
granted -
US 11778995
Genetically modified non-human animals and methods of use thereof
granted -
US 11780907
Human antibodies to influenza hemagglutinin
granted -
US 11779633
Glucagon-like peptide 1 receptor agonists and uses thereof
granted -
US 11771762
Anti-ErbB3 antibodies and uses thereof
granted -
US 11773393
Treatment of liver diseases with cell death inducing DFFA like effector B (CIDEB) inhibitors
granted -
US 11773156
Anti-hemagglutinin antibodies and methods of use thereof
granted -
US 11771743
Methods for preventing or treating allergy by administering an IL-4R antagonist
granted -
US 11766032
Genetically modified non-human animals expressing human EPO
granted -
US 11767526
Treatment of ophthalmic conditions with angiopoietin-like 7 (ANGPTL7) inhibitors
granted -
US 11767358
Human antibodies to Bet v 1 and methods of use thereof
granted -
US 11769597
Methods of associating genetic variants with a clinical outcome in patients suffering from age-related macular degeneration treated with anti-VEGF
granted -
US 11760775
Steroids and protein-conjugates thereof
granted -
US 11759476
Methods of treating metabolic disorders and cardiovascular disease with Inhibin Subunit Beta E (INHBE) inhibitors
granted -
US 11753628
HSD17B13 variants and uses thereof
granted -
US 11753459
Anti-VEGF protein compositions and methods for producing the same
granted